Critical care management of potential organ donors: Our current standard

Clinical Transplantation

Volumn 23, Issue SUPPL.21, 2009, Pages 2-9

  Dictus, C ^a   Vienenkoetter, B ^a   Esmaeilzadeh, M ^b   Unterberg, A ^a   Ahmadi, R ^a  

^a Department of Neurosurgery ^*  (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain death; Critical care management; Donor candidate; Pathophysiological considerations; Standardized treatment strategies

Indexed keywords

AMIODARONE; DOPAMINE; ESMOLOL; ISOPRENALINE; LIDOCAINE; NITROPRUSSIDE SODIUM; THROMBOPLASTIN; URAPIDIL; VASOPRESSIN;

ADRENERGIC SYSTEM; AIRWAY PRESSURE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BRAIN DEATH; BRONCHOPNEUMONIA; DIABETES INSIPIDUS; DIABETES MELLITUS; DOWN REGULATION; DRUG MEGADOSE; ENDOCRINE DISEASE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GRAFT SURVIVAL; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; HYPOVOLEMIA; INTENSIVE CARE; INTRACRANIAL PRESSURE; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIVER FUNCTION; MEAN ARTERIAL PRESSURE; ORGAN DONOR; ORGAN TRANSPLANTATION; PERFUSION PRESSURE; PLASMINOGEN ACTIVATION; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTHROMBIN TIME; REVIEW; STANDARD; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VASOMOTOR REFLEX;

BRAIN DEATH; CRITICAL CARE; DISSEMINATED INTRAVASCULAR COAGULATION; HEMODYNAMICS; HUMANS; PATIENT CARE PLANNING; TISSUE DONORS;

EID: 70649088687     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01102.x     Document Type: Review

References (81)

1. Lopez-Navidad A, Domingo P, Caballero F. Organ shortage: viability of potential organ donors and possible loss depend on health care workers who are responsible for the organ procurement program. Transplant Proc 1997, 29:3614.
2. Grossman R. Early enteral formula administration. Crit Care Med 1995, 23:436.
3. Nygaard CE, Townsend RN, Diamond DL. Organ donor management and organ outcome: a 6-year from a level 1 trauma center. J Trauma 1990, 30:728.
4. Van Bakal AB. The cardiac transplant donor: identification, assessment, and management. Am J Med Sci 1997, 314:153.
5. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplant Proc 1997, 29:3770.
6. Novitzky D. Donor management: state of the art. Transplant Proc 1997, 29:3773.
7. Tuttle-Newhall JE, Collins BH, Kuo PC, Schoeder R. Organ donation and treatment of the multi-organ donor. Curr Probl Surg 2003, 40:266.
8. Shivarlkar B, Van Loon J, Wieland W. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993, 87:230.
9. Carber C, Manyalich M, Valero R, Garcia-Fages LC. Timing used in the different phases of the organ procurement process. Transplant Proc 1992, 24:22.
10. Kosieradzki M, Kuczynska J, Piwowarska J. Prognostic significance injury occurring in the kidney donor. Transplantation 2003, 75:1221.
11. Lagiewska B, Pacholczyk M, Szostek M, Walaszewski J, Rowinski W. Hemodynamic and metabolic disturbances observed in brain-dead organ donors. Transplant Proc 1996, 28:165.
12. Finfer S, Bohn D, Colpitts D, Cox P, Fleming F, Barker G. Intensive care management of pediatric organ donors and its effect on post transplant organ function. Intensive Care Med 1996, 22:1424.
13. Van der Hoeven JA, Ter Horst GJ, Molema G. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000, 232:804.
14. Kusaka M, Pratschke J, Wilhelm MJ. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000, 69:405.
15. Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR. Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. Transplantation 1993, 55:442.
16. Hoemme R, Neeser G. Organ donation. Anaesthesist 2007, 56:1291.
17. Power BM, Van Heerden PV. The physiological changes associated with brain death-current concepts and implantations for treatment of the brain dead organ donor. Anaesth Intensive Care 1995, 23:26.
18. Zaroff JG, Rosengard BR, Armstrong WF. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations March 28-29 2001, Crystal City, Va. Circulation 2002, 106:836.
19. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicenter analysis. Nephrol Dial Transplant 1999, 14:1517.
20. Reilly PM, Grossman M, Rosengard BRE. Lung procurement from solid organ donors: role of fluid resuscitation in procurement failures. Chest 1996, 110:222S.
21. Rosengard BR, Feng S, Alfrey EJ. Report of the crystal city meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002, 2:701.
22. Hevesi ZG, Lopukhin SY, Angelini G, Coursin DB. Supportive care after brain death for the donor candidate. Int Anesthesiol Clin 2006, 44:21.
23. Wood KE, Becker BN, Mccartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. NEJM 2004, 351:2730.
24. Wheeldom DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the unacceptable donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995, 14:734.
25. Potter CD, Wheeldon DR, Wallwork J. Functional assessment and management of heart donors: a rationale for characterization and a guide to therapy. J Heart Lung Transplant 1995, 14:59.
26. Debaveye YA, Van den Berghe GH. Is there still a place for dopamine in the modern intensive care unit?. Anesth Analg 2004, 98:461.
27. Marik PE, Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994, 272:1354.
28. Tilney NL, Paz D, Ames J, Gasser M, Laskowski I, Hancock WW. Ischemia-reperfusion injury. Transplant Proc 2001, 33:843.
29. Amado JA, Lopez-Espadas F, Vazquez-Barquero A. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism 1995, 44:812.
30. Stangl M, Zerkaulen T, Theodorakis J. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001, 33:1284.
31. Iwai A, Sakano T, Uenishi M, Sugimoto H, Yoshioko T, Sugimoto T. Effects of vasopressin and cathecholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989, 48:613.
32. Katz K, Lawler J, Wax J, O'Connor R, Nadkarni V. Vasopressin pressor effects in critically ill children during evaluation for brain death and organ recovery. Resuscitation 2000, 47:33.
33. Hunt SA, Baldwin J, Baumgartner W. Cardiovascular management of a potential heart donor: a statement from the transplantation committee of the American College of Cardiology. Crit Care Med 1996, 24:1599.
34. Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002, 122:699.
35. Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain stem dead donors. A possible role for hormonal replacement therapy. Transplantation 1989, 47:828.
36. Gramm HJ, Meinhold H, Bickel U. Acute endocrine failure after brain death?. Transplantation 1992, 54:851.
37. Shah VR. Aggressive management of multiorgan donor. Transplant Proc 2008, 40:1087.
38. Avlonitis VS, Fisher AJ, Kirby JA, Dark JH. Pulmonary transplantation: the role of brain death in donor lung injury. Transplantation 2003, 75:1928.
39. Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD. Medical management to optimize donor organ potential: review of the literature. Can J Anaesth 2006, 53:820.
40. Wood KE, Coursin DB. Intensivists and organ donor management. Curr Opin Anaesthesiol 2007, 20:97.
41. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain dead organ donors. Transplantation 1993, 56:1418.
42. Aziz TM, El-Gamel A, Saad RA, Migliore M, Campbell CS, Yonan NA. Pulmonary vein gas analysis for assessing donor lung function. Ann Thorac Surg 2002, 73:1599.
43. Gabbay E, Williams TJ, Griffiths AP. Maximizing the utilization of donor organ offered for lung transplantation. Am J Respir Crit Care Med 1999, 160:265.
44. Follette D, Rudich S, Bonacci C, Allen R, Hoso A, Albertson T. Importance of an aggressive multidisciplinary management approach to optimize lung donor procurement. Transplantation Proc 1999, 31:169.
45. Tanaka N. Radiologic-pathologic correlation of experimental bleomycin-induced pneumonitis. Nippon Iqaku Hoshasen Gakkai Zasshi 1993, 53:1392.
46. Wilheim S, Maze M. Controversial issues in adult and paediatric ambulatory anaesthesia: is there a role for alpha-2 agonist in conscious sedation in adults and paediatric ambulatory surgical practice. Curr Opin Anaesthesiol 2000, 13:619.
47. Postema S, Pattynama PM, van Rijswijk CS, Trimbos JB. Cervical carcinoma: can dynamic contrast enhanced MR imaging help predict tumor aggressiveness. Radiology 1999, 210:217.
48. De Boer ML, Hu J, Kalvakolanu DV, Hasdav JD, Cross AS. INF gamma inhibits lipopolysaccharide-induced interleukin 1 beta in primary murine macrophages via a Stat 1 dependent pathway. J Interferon Cytokine Res 2001, 21:485.
49. Van der Wounde FJ, Ferrario F. Renal involvement in ANCA associated systemic vasculitis. J Nephrol 1999, 12:105.
50. Itoh M, Kuroda K. Impressions on 11th international conference on Nagative Strand Viruses. Uirusu 2000, 50:319.
51. Zivna H, Zivny P, Navratil P. The role of cytokines and antioxidant status in graft quality prediction. Transplant Proc 1999, 31:2094.
52. Nagareda T, Kinoshita Y, Tanaka A. Clinicopathology of kidneys from brain dead patients treated with vasopressin and epinephrine. Kidney Int 1993, 43:1363.
53. Pratschke J, Wilhelm MJ, Kusaka M. Accelerated rejection of renal allograft from brain dead donors. Ann Surg 2000, 232:263.
54. Schnuelle P, Berger S, de Boer J, Persijn G, van der Wounde FJ. Effects of catecholamine application to brain dead donors on graft survival in solid organ transplantation. Transplantation 2001, 72:455.
55. Schnuelle P, Lorenzo D, Mueller A, Trede M, Van der wounde FJ. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999, 56:738.
56. Singer AC, Wong CS, Crowley DE. Differential enantioselective transformation of atropisomeric polychlorinated biphenyls by multiple bacterial strains with different including compounds. Appl Environ Microbiol 2002, 68:5756.
57. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic contrast agent induced reductions in renal function by acetylcysteine. N Engl J Med 2000, 343:180.
58. Efrati S, Dishy V, Averbukh M. The effect of N-acetylcycteine on renal function, nitric oxide and oxidative stress after angiography. Kidney Int 2003, 64:2182.
59. Briguori C, Manganelli F, Scarpato P. Acetylcysteine and contrast agent associated nephrotoxicity. J Am Coll Cardiol 2002, 40:298.
60. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography related renal tissue injury (the APART trial). Am J Cardiol 2002, 89:356.
61. Kay J, Chow WH, Chan TM. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003, 289:553.
62. Merten GJ, Burgess WP, Rittase RA, Kennedy TP. Prevention of contrast induced nephropathy with sodium bicarbonate: an evidence based protocol. Crit Pathw Cardiol 2004, 3:138.
63. Ploeg RJ, D'Alessandro AM, Knechtle SJ. Risk factoers for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993, 55:807.
64. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992, 53:957.
65. Brokelman W, Stel AL, Ploeg RJ. Risk factors for primary dysfunction after liver transplantation in the university of Wisconsin solution era. Transplant Proc 1999, 31:2087.
66. Porte RJ, Ploeg RJ, Hansen B. Lonh term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicenter Study Group. Transpl Int 1998, 11(Suppl. 1):S164.
67. Figueras J, Busquets J, Grande L. The deleterious effect of donor high plasma sodium and extrended preservation in liver transplantation. A multivariate analysis. Transplantation 1996, 61:410.
68. Gonzalez FX, Rimola A, Grande L. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994, 20:565.
69. Totsuka E, Dodson F, Urakami A. Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Kidney Transpl Surg 1999, 5:421.
70. Sazontseva IE, Kozlov IA, Moisuc YG, Ermolenko AE, Afonin VV, Ilnitskiy VV. Hormonal response to brain death. Transplant Proc 1991, 23:2467.
71. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120:989.
72. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain dead potential organ donors. Transplantation 1987, 43:852.
73. Rosendale JD, Kauffman HM, McBride MA. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003, 75:482.
74. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. THYROID 1997, 7:139.
75. Salim A, Vassiliu P, Velmahos GC. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001, 136:1377.
76. Pratschke J, Wilhelm MJ, Kusaka M. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999, 67:343.
77. Birks EJ, Burton PB, Owen V. Elevated tumor necrosis factor alpha and interleukin 6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000, 102(Suppl. 3):III 52.
78. Nijboer WN, Schuurs TA, van der Hoeven JA. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc. 2005, 37:367-9. Jan-Feb
79. Gores PF, Gillingham KJ, Dunn DL, Moudry-Munns KC, Najarian JS, Sutherland DE. Donor hyperglycemia as a minor risk factor and immunologic variables as major risk factors for pancreas allograft loss in a multivariate analysis of a single institution s experience. Ann Surg 1992, 215:217.
80. Smith M. Physiologic changes during brain stem death lessons for management of the organ donor. J Heart Lung Transplant 2004, 23:S217.
81. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL. Hormonal changes in brain dead patients. Crit Care Med 1990, 18:702.